Latest stories on BBOT
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
BridgeBio Oncology Therapeutics, Inc. (BBOT) files 8-K
SEC 8-K50 · neutralgeneral
BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
Business Insider56 · neutralgeneral
BridgeBio Oncology Therapeutics: KRAS Program Data Due 2H26 May Reignite Bullish Sentiment
Seeking Alpha65 · bullishproduct/pr
BridgeBio Oncology Holders Elect Directors, Ratify Auditor
TipRanks50 · neutralgeneral
BridgeBio Oncology Therapeutics, Inc. (BBOT) files 8-K
SEC 8-K50 · neutralgeneral